All Posts: GLP-1 receptor agonists

• An Overlooked Hormone Eyed as Deadly Driver of Postmenopausal Breast Cancer in Women with Obesity

  A new analysis of research into the most common type of breast cancer has zeroed in on an overlooked hormone that may be responsible for the increased risk of breast cancer death in postmenopausal women with obesity. It also raises the possibility that treatment of these aggressive breast cancers could be improved with the addition of weight-loss drugs known as GLP-1 receptor agonists.

  Category: News Release Tags: breast cancer, breast cancer research, cancer, GLP-1 receptor agonists, obesity and cancer